TITLE

Trastuzumab (Herceptin) and HER2-positive breast cancer

AUTHOR(S)
Murray, Sally
PUB. DATE
January 2006
SOURCE
CMAJ: Canadian Medical Association Journal;1/3/2006, Vol. 174 Issue 1, p36
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article provides information on a randomized trial which studied the effectiveness of trastuzumab after adjuvant chemotherapy in women with human epidermal growth factor receptor 2-positive breast cancer. Treatment with trastuzumab reduced the incidence of cancer recurrence among the patients. Absolute risk reductions outline the drug's contribution to disease-free survival but were weighed against its known cardiotoxic effects.
ACCESSION #
19229251

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics